Clinical Trials Directory

Trials / Unknown

UnknownNCT03202082

Impact of Neuropsychological Evaluation on Epilepsy Treatment

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of South Florida · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The present study aims to expand the evidence base of neuropsychological services in the context of medical management of epilepsy, examining whether treatment outcome and patient satisfaction with medical care are significantly improved when neuropsychological evaluation is included as an additional component of medical care within a comprehensive epilepsy center. All participants will complete an initial survey and a follow-up survey regarding views towards their epilepsy treatment. Participants will be randomized into one of two groups. One group will be given a neuropsychological battery in addition to the survey. The primary study hypothesis is that the addition of neuropsychological services to treatment-as-usual will result in significant improvements in (a) satisfaction with medical care, (b) patient perceived treatment outcome, and (c) physician-rated medical compliance. The secondary hypothesis is that participants who undergo neuropsychological evaluation will be generally satisfied with their experience with neuropsychological services.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNeuropsychological testingNeuropsychological testing evaluates various aspects of a participants cognitive ability as well as mood.

Timeline

Start date
2015-07-01
Primary completion
2018-06-30
Completion
2018-06-30
First posted
2017-06-28
Last updated
2017-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03202082. Inclusion in this directory is not an endorsement.